News Centre

Innovation and collaboration are key in the battle against multiple myeloma

Dr Bríd Seoighe, Medical Director, commercial business at Janssen Sciences Ireland UC, shines a light in The Irish Times on the second most common type of blood cancer in Europe - Multiple Myeloma.

Bringing us closer to the goal of a future without disease

Dr Thorsten Giesecke, general manager, commercial business at Janssen Sciences Ireland UC outlines how clinical trials play a critical role in addressing the unmet need in the treatment of the blood cancer, multiple myeloma, and bring us closer to the goal of a future without disease.

Janssen Ireland expand Cork facility with possible creation of 180 jobs

Janssen Sciences Ireland is expanding its biopharmaceutical supply chain facility in Ringaskiddy, Co Cork. The facility, which is part of the Johnson & Johnson group, will see a €150 million investment.

Innovation can change the trajectory of human health

The values that guide our decision-making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.

An Interview With Janssen Ireland General Manager – Thorsten Giesecke

In an article published in the Irish Times, Dr. Thorsten Giesecke spoke about how a new era of partnership between the Government, the health service and industry will be vital to achieving the best for Irish patients and how Janssen Ireland are committed to putting the patient first

CP-396019 | August 2023

Title

News Centre

Innovation and collaboration are key in the battle against multiple myeloma

Bringing us closer to the goal of a future without disease

Janssen Ireland expand Cork facility with possible creation of 180 jobs

Innovation can change the trajectory of human health

An Interview With Janssen Ireland General Manager – Thorsten Giesecke